Blaze is developing a line of products for rapid and easy testing of stored blood properties relating to quality loss during storage.
Throughout the history of blood transfusion, “time” has been the only available approximation for quality loss - as shown with a uniform shelf-life, and first-in-first-out inventory practices. However, countless other factors can affect a unit’s viability, quality and efficacy, causing significant variability among degradation levels and rates. Blaze’s technology helps bypass the controversy over whether “fresher” blood is better to transfuse than “older” blood by presenting a unit-specific metric directly capturing actual blood properties relevant to its performance upon transfusion. Various clinical and/or blood-management decisions could potentially be enhanced by uncovering this information during storage.

